The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The Auditor's assessment (at sign off date):P42: Key Audit Matter: Going concern (Group and parent company – Note 2)
As part of our audit, we have performed the following procedures:
• Reviewed management’s assessment of going concern to 31 December 2025 and assessed the reasonableness of key assumptions and inputs used by management;
• Evaluated and corroborated the key assumptions and inputs underlying the budgets and cash flow forecasts, including sensitivity analysis against the base case scenario;
• Discussed with management how they intend to fund the clinical trials and other clinical programs, including an assessment of the funding options currently under negotiation;
• Compared management’s forecasts to actual results through the subsequent events period and performed inquiries to the date of this report;
• Assessed the probability of obtaining additional sources of funds when required, together with the ability to defer research and development expenditure; and
• Assessed the disclosures made regarding going concern in the financial statements for consistency with management’s assessment.
The group intends to progress its key development project to clinical trials together with the performance of other clinical programs. Significant additional funds will be required in order to progress as planned, which are not yet agreed and unconditional. As disclosed in Note 2, the group has a high proportion of discretionary expenditure which it is able to defer, if sufficient funding is not available.
The situation just over two weeks ago, assessed by those with knowledge:
P56 Annual Report: Going Concern
The Company has not experienced and does not anticipate that there will be any impact, including on its personnel or supply chain, as a result of the on-going war in Ukraine or the situation in the Middle East save for a general increase in inflation such as of the cost of energy.
The Company successfully raised £5.25 million (before expenses) through the allotment and issue of new ordinary shares during the year ended 31 December 2023, and a further £3.25 million in early 2024. These proceeds were raised in order to facilitate the progression of the Company's HEMO- CAR-T product candidate into clinical trials and to enable the Company to continue development of product candidates for the treatment of viral infections and cancers based on its CBR platform.
Funding will be required by the Company to complete Phase I clinical development.
The Company cannot be certain that such additional funding will be available on acceptable terms, or at all. To the extent that the Company raises additional funds by issuing equity securities, the Company’s stockholders may experience dilution. Any debt financing, if available, may involve restrictive covenants. If the Company is unable to raise additional capital when required or on acceptable terms, it may have to (i) significantly delay, scale back or discontinue the development and/or commercialisation of one or more product candidates; (ii) seek collaborators for product candidates at an earlier stage than otherwise would be desirable and on terms that are less favourable than might otherwise be available; or (iii) relinquish or otherwise dispose of rights to technologies, product candidates or products that it would otherwise seek to develop or commercialise on unfavourable terms.
However, the Directors are of the opinion that the Company has adequate working capital to execute its operations for the present time and is confident in its ability to access additional financing over the next 12 months. The Directors, therefore, have made an informed judgement, at the time of approving these financial statements, that there is a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. As a result, the Directors have continued to adopt the going concern basis of accounting in preparing the annual financial statements.
Is Vlad finally out of options? How can he possibly progress without further funding and where is that coming from?
And where are the old faithfuls? Hedge. JHFH. The usual lot.
Is Vlad to pharma what George Roach is to lithium?
Yes agree a positive RNS would definitely give the share price a mega boost. Let's wait and see what happens when it lands I'm happy to buy and hold. If you know you know
3 months since the placing, if they dont get a shift on they will be raising again for the same trial.
A positive RNS will ensure the confidence and sentiment changes here…
Just wait for the RNS to land do not rush the science.
I know it's not been a simple and easy ride however it is all coming together now and work is being done in the background behind the scenes.. So just chill and enjoy the journey
Buying & Holding 4 Gold
Dhub ... Thanks for providing the update and all we can do is HOPE that Vlad is being truthful and this breakthrough is not a pump (via kingpin) and an RNS is due soon. It's a great opportunity for hemo to help the market and the share price as this silence is crazy ... nearly 3 months and still no update on trials which were supposed to be in 2023 !!! At present the investors don't believe in the email as the sells continue ...
I've seen the email. KIngpin is in regular contact with Vlad. I've seen his email and the full reply from Vlad. It is up to him if he wants to share it, but I don't think he should personally. He has a good rapport with Vlad and if he shares it, that correspondence may cease. Also imo, anything Vlad writes you can take it with a pinch of salt as far as I'm concerned. We should just wait for a RNS to confirm everything (should it happen). Shall we say, I am hopeful, but always wary.
Has anyone shared this email since many here don't trust it is real ... if real, then a breakthrough is very exciting times soon
"I’m certain of a breakthrough soon” will do for me
You have to be in it to win it
Buying and holding for Gold...
Not very good if you missed the "pump"from $2.59 to $3.10'So much for the "so called expert analysis "boiler room scam" Low of $0.50,now $0.72/ After 3 years Mustang being readmitted to main market"Be funny if I can make a profit on that before you do with Hemo 😆
''PJT, I can't believe anyone would actually read anything serious into that post about the breakthrough but if they do then more fool them'' Cant you Sscc, you cant believe it? bully for you. When it all goes t*ts up do come back and tell us you told us so . ''I did predict 1.5p...'' yawn. Im sure somebody has a medal in a drawer for you somewhere.
Hows that tip you gave us all pumpky..EJH wasn't it ?
MR and Mrs I "suddenly stopped posting "obviously thinking we will forget 😆
Afternoon All ,
back after a beautiful week on the water 👍⚓️⛴️
Cogs will be turning despite no news
( mentioned before but worth noting despite some investors becoming impatient)
Prevail ain’t no naive muppets , they are a professional organisation who backed Hemos science & tossed a wedge in a lot higher than current stock price ,
I’m sure Vlad & Prevail are investigating all potential avenues for the benefit of Hemo & stockholders including Prevail .
Noted by Prevail in Sept RNS 👍
Mary Schaheen, President of Prevail Partners, stated: "Everyone at our fund is confident in the growth and success of Hemogenyx Pharmaceuticals as they develop CAR-T cells to target acute myeloid leukemia. Furthermore, Hemogenyx Pharmaceuticals has a seasoned management team with the expertise to accelerate the company to a significant value inflection point through the completion of its planned clinical trial."
Stock needs volume & positive news will bring volume & stock re rate imo .
To note -
Updated -
Stock on loan / shorts
Current 4.2 million
Last Wednesday 5.55 million
Week before 5.3 million
Friday 4.75 million
& a 4.2 million short was opened 2 days after placement news @1.62 - 3 months ago & costing daily to borrow stock -
Currently underwater - unlucky 👎
So i am sceptical on any stock & any forums with continuous negativity been posted by a few with recent shorts opened , very risky in Hemo’s current position imo
Hemo are clinical & working with Prevail on CAR T 👍
With CBR & CDX cooking 👍
Good products will attract financial pharmas once news is confirmed. Imo 👍👍
Let’s see what next few months bring
5% today potential 500% in the future imo .
I didn't plan to buy anymore, but I've also just had a top up. I have a good feeling of good news soon. GLA
13 May 2024 BUY HEMO LSE 500,000 1.59p £8,014.33
Well luck has to change so just topped at 1.59 4 years need to hope for turn of fortune gla
Someone has been on the pop and it's not pumpky.
Someone
Explain your 12.27 post then The 1st 3 words 🤔
Ha, if you actually look at the two profiles you'll see that, aside from the name, we couldn't be more dissimilar in our emotions and outlook, let alone spelling and grammar. A high number of my posts have also called out MrI's emotional posts that seem to change daily. If you actually read through and think there's a chance we're the same person then you've been on too much pop.
I was wondering what that was all about. So dodgy 😂
Guess MR I Forgot to log off and log on as MRS I 🙃
Crazy loons lol